Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction

NCT02474199 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Liver Transplant Recipient
Living Donor (of the Respective Liver Transplant Recipient)

Interventions

BIOLOGICAL: darTregs
DRUG: Acetaminophen
DRUG: Diphenhydramine
DRUG: Immunosuppression (IS) Withdrawal
PROCEDURE: Study Mandated Procedures

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]